Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Erratum: A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions.

Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, Zachos NC.

Sci Rep. 2017 May 3;7:46790. doi: 10.1038/srep46790. No abstract available.

2.

A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions.

Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, Zachos NC.

Sci Rep. 2017 Mar 27;7:45270. doi: 10.1038/srep45270. Erratum in: Sci Rep. 2017 May 03;7:46790.

3.

Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.

Staab JF, Neofytos D, Rhee P, Jiménez-Ortigosa C, Zhang SX, Perlin DS, Marr KA.

Antimicrob Agents Chemother. 2014 Sep;58(9):5421-7. doi: 10.1128/AAC.00096-14. Epub 2014 Jun 30.

4.

Epidemiology of Candida kefyr in patients with hematologic malignancies.

Dufresne SF, Marr KA, Sydnor E, Staab JF, Karp JE, Lu K, Zhang SX, Lavallée C, Perl TM, Neofytos D.

J Clin Microbiol. 2014 Jun;52(6):1830-7. doi: 10.1128/JCM.00131-14. Epub 2014 Mar 12.

5.

Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans.

Staab JF, Datta K, Rhee P.

PLoS One. 2013 Nov 8;8(11):e80842. doi: 10.1371/journal.pone.0080842. eCollection 2013.

6.

Discrimination of Aspergillus lentulus from Aspergillus fumigatus by Raman spectroscopy and MALDI-TOF MS.

Verwer PE, van Leeuwen WB, Girard V, Monnin V, van Belkum A, Staab JF, Verbrugh HA, Bakker-Woudenberg IA, van de Sande WW.

Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):245-51. doi: 10.1007/s10096-013-1951-4. Epub 2013 Sep 13.

PMID:
24030717
7.

Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.

Datta K, Rhee P, Byrnes E 3rd, Garcia-Effron G, Perlin DS, Staab JF, Marr KA.

J Clin Microbiol. 2013 Sep;51(9):3090-3. doi: 10.1128/JCM.01190-13. Epub 2013 Jun 26.

8.

Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.

Dufresne SF, Datta K, Li X, Dadachova E, Staab JF, Patterson TF, Feldmesser M, Marr KA.

PLoS One. 2012;7(8):e42736. doi: 10.1371/journal.pone.0042736. Epub 2012 Aug 10.

9.

Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation.

Chaudhary N, Datta K, Askin FB, Staab JF, Marr KA.

Am J Respir Crit Care Med. 2012 Feb 1;185(3):301-10. doi: 10.1164/rccm.201106-1027OC. Epub 2011 Dec 1.

10.

Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.

Staab JF, Kahn JN, Marr KA.

Antimicrob Agents Chemother. 2010 Dec;54(12):4992-8. doi: 10.1128/AAC.00774-10. Epub 2010 Sep 20.

11.

Hairpin dsRNA does not trigger RNA interference in Candida albicans cells.

Staab JF, White TC, Marr KA.

Yeast. 2011 Jan;28(1):1-8. doi: 10.1002/yea.1814. Epub 2010 Aug 24.

12.

Healthy human T-Cell Responses to Aspergillus fumigatus antigens.

Chaudhary N, Staab JF, Marr KA.

PLoS One. 2010 Feb 17;5(2):e9036. doi: 10.1371/journal.pone.0009036.

13.

Aspergillus section Fumigati typing by PCR-restriction fragment polymorphism.

Staab JF, Balajee SA, Marr KA.

J Clin Microbiol. 2009 Jul;47(7):2079-83. doi: 10.1128/JCM.00551-09. Epub 2009 Apr 29.

14.

Genome-wide transcriptional profiling of the cyclic AMP-dependent signaling pathway during morphogenic transitions of Candida albicans.

Bahn YS, Molenda M, Staab JF, Lyman CA, Gordon LJ, Sundstrom P.

Eukaryot Cell. 2007 Dec;6(12):2376-90. Epub 2007 Oct 19.

15.

State of differentiation defines buccal epithelial cell affinity for cross-linking to Candida albicans Hwp1.

Ponniah G, Rollenhagen C, Bahn YS, Staab JF, Sundstrom P.

J Oral Pathol Med. 2007 Sep;36(8):456-67.

PMID:
17686003
17.

Candida albicans HWP1 gene expression and host antibody responses in colonization and disease.

Naglik JR, Fostira F, Ruprai J, Staab JF, Challacombe SJ, Sundstrom P.

J Med Microbiol. 2006 Oct;55(Pt 10):1323-7.

18.

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.

Hakki M, Staab JF, Marr KA.

Antimicrob Agents Chemother. 2006 Jul;50(7):2522-4.

19.

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.

Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA.

J Clin Microbiol. 2006 May;44(5):1740-3.

21.

The adhesin Hwp1 and the first daughter cell localize to the a/a portion of the conjugation bridge during Candida albicans mating.

Daniels KJ, Lockhart SR, Staab JF, Sundstrom P, Soll DR.

Mol Biol Cell. 2003 Dec;14(12):4920-30. Epub 2003 Oct 17.

22.
23.

URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes.

Staab JF, Sundstrom P.

Trends Microbiol. 2003 Feb;11(2):69-73. Review.

PMID:
12598128
25.

Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

Staab JF, Bradway SD, Fidel PL, Sundstrom P.

Science. 1999 Mar 5;283(5407):1535-8.

27.
28.
29.

EntG activity of Escherichia coli enterobactin synthetase.

Staab JF, Earhart CF.

J Bacteriol. 1990 Nov;172(11):6403-10.

30.

Nucleotide sequence of the Escherichia coli entE gene.

Staab JF, Elkins MF, Earhart CF.

FEMS Microbiol Lett. 1989 May;50(1-2):15-9.

PMID:
2525505

Supplemental Content

Loading ...
Support Center